Your Source for Venture Capital and Private Equity Financings

Protenus Raises $21M Series D Round

2021-06-15
BALTIMORE, MD, Protenus announced today a $21 million investment from some of the country's top healthcare technology investment firms.
Protenus, the nation's leading healthcare compliance analytics firm, announced today a $21M investment from some of the country's top healthcare technology investment firms. Protenus helps thousands of hospitals reduce risk and scale compliance by eliminating unauthorized EMR snooping and narcotic drug diversion, intractable and growing threats throughout the industry.

Protenus has continued to transform the industry with its ground-breaking AI-powered analytics. All existing investors - including Transformation Capital, Providence Ventures, F-Prime Capital, Kaiser Permanente Ventures, Arthur Ventures, and Lionbird - joined MemorialCare as well as Gaingels in contributing to the $21M Series D funding round, which will accelerate growth and continued product innovation.

Protenus uses artificial intelligence to reduce risk and save resources for the nation's leading health systems. Compliance analytics provide healthcare leaders full insight into how health data is being used and alerts privacy, pharmacy and compliance teams to inappropriate activity that puts patients and their data at risk. For two consecutive years, Protenus was named one of Forbes' Best Startup Employers and one of CBInsights Digital Health 150. Protenus was also named the 2020 and 2019 KLAS Category Leader in Patient Privacy Monitoring. Protenus was named one of The Best Places to Work in Healthcare by Modern Healthcare for four straight years, one of the Best Places to Work in Baltimore by the Baltimore Business Journal, and the Baltimore Sun. Protenus was also recognized as a "Cool Vendor" in Healthcare Artificial Intelligence by Gartner, Inc. Learn more at Protenus.com and follow us on Twitter @Protenus.
(c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000 startups and 5,000 VC investors